Insider · CIK 0001762583
Lawrence Otto Klein
Files at ORKA (Oruka Therapeutics, Inc.), JBIO (Jade Biosciences, Inc.). First filing Sep 1, 2026, latest Oct 2, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ORKA: Oruka Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Oruka Therapeutics, Inc. | $2.1M 25,000 shares | -3% | +348% from low-26% from high | |
| 53Moderate | Oruka Therapeutics, Inc. | $235k 2,452 shares | -0% | - | |
| 30Weak | Oruka Therapeutics, Inc. | $6.9M 75,000 shares | -7% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ORKA Oruka Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +25,000 | $7.80 | $195k | 948,128 | 10 d ago |
| Oct 1, 2026 | ORKA Oruka Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -16,246 | $83.40 | $1.4M | 931,882 | 10 d ago |
| Oct 1, 2026 | ORKA Oruka Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,554 | $84.03 | $719k | 923,328 | 10 d ago |
| Oct 1, 2026 | ORKA Oruka Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -200 | $84.78 | $17k | 923,128 | 10 d ago |
| Oct 1, 2026 | ORKA Oruka Therapeutics, Inc. | MOption exercise Employee Warrant (right to buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 1,528,513 | 10 d ago |
| Sep 15, 2026 | ORKA Oruka Therapeutics, Inc. | SOpen-market sale Common Stock | -2,452 | $95.71 | $235k | 923,128 | 27 d ago |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +75,000 | $7.80 | $585k | 1,000,580 | 41 d ago |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,604 | $90.79 | $600k | 993,976 | 41 d ago |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -63,596 | $91.90 | $5.8M | 930,380 | 41 d ago |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,800 | $92.44 | $444k | 925,580 | 41 d ago |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | MOption exercise Employee Warrant (right to buy)derivative10b5-1 | -75,000 | $0.00 | $0 | 1,553,513 | 41 d ago |
| Apr 29, 2025 | JBIO Jade Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +23,017 | $0.00 | $0 | 23,017 | May 1, 2025 |
| Jan 22, 2025 | ORKA Oruka Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +230,000 | $0.00 | $0 | 230,000 | Jan 24, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.